trial

Cognitive Remediation of Schizophrenia in a Community Mental Health Setting

NCTId NCT01988714
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 112 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2016-09-26
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
112 (actual)
Study type
Interventional
Allocation
Randomized
Model
Single Group
Masking
Single
Start
2009-09
Primary completion
2016-09-26
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
(TCT) plus evidence-based SE(CG) plus evidence-based SE

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor

Investigators

1
Sophia Vinogradov, MDPrincipal Investigator

Sites

1 total
San Francisco, United States

Facts & assertions

4 sourced
Enrollment
112
Phase
NA
Primary Completion Date
2016-09-26
Status
COMPLETED
relationships
The graph out of here
drug
(TCT) plus evidence-based SE
drug
(CG) plus evidence-based SE
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
indication
Experimental Condition TCT
indication
Controlled Condition CG
indication
investigator
Sophia Vinogradov, MD
person